Diagnostic Microbiology & Infectious Disease
Volume 54, Issue 1 , Pages 57-62 , January 2006

Antimicrobial susceptibility of Haemophilus influenzae isolates collected from 4 centers in Brazil (1990–2003)

  • Antonio Eugenio Castro Cardoso de Almeida

      Affiliations

    • Departamento de Microbiologia/Fundação Oswaldo Cruz/FIOCRUZ, Instituto Nacional de Controle da Qualidade em Saúde (INCQS), Rio de Janeiro 21045-900, RJ, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-21-3865-5236; fax: +55-21-2290-0915.
    • ,
  • Ivano de Filippis

      Affiliations

    • Departamento de Microbiologia/Fundação Oswaldo Cruz/FIOCRUZ, Instituto Nacional de Controle da Qualidade em Saúde (INCQS), Rio de Janeiro 21045-900, RJ, Brazil
    • ,
  • Diana Guedes Ferreira

      Affiliations

    • Departamento de Microbiologia/Fundação Oswaldo Cruz/FIOCRUZ, Instituto Nacional de Controle da Qualidade em Saúde (INCQS), Rio de Janeiro 21045-900, RJ, Brazil
    • ,
  • Alessandra Oliveira de Abreu

      Affiliations

    • Departamento de Microbiologia/Fundação Oswaldo Cruz/FIOCRUZ, Instituto Nacional de Controle da Qualidade em Saúde (INCQS), Rio de Janeiro 21045-900, RJ, Brazil
    • ,
  • Cristina Rebelo

      Affiliations

    • Instituto Estadual de Infectologia S. Sebastião, Secretaria Estadual de Saúde, Rio de Janeiro 20931-000, RJ, Brazil
    • ,
  • André Luis Gemal

      Affiliations

    • Departamento de Microbiologia/Fundação Oswaldo Cruz/FIOCRUZ, Instituto Nacional de Controle da Qualidade em Saúde (INCQS), Rio de Janeiro 21045-900, RJ, Brazil
    • ,
  • Keyla Belízia Feldman Marzochi

      Affiliations

    • Instituto de Pesquisas Evandro Chagas (IPEC), Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21045-900, RJ, Brazil

Received 12 April 2005 ,Accepted 2 August 2005.

References 

  1. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zeel ER, Broome CV, et al. Decline of childhood Hi type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221–226
  2. Black SB, Shinefield HR the Kaiser permanent vaccine study group. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large HMO population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. Pediatr. Infect. Dis. J. 1992;11:610–613
  3. Bokermann S, Zanella RS, Lemos APS, De Andrade ALSS, Brandileone MCC. Evaluation of methodology for serotypes invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil. J. Clin. Microbiol. 2003;41:5546–5550
  4. Campos J. Haemophilus influenzae. In:  Murray PR,  Barron EJ,  Pfaller MA,  Tenover FC,  Yolken RH editor. Manual of clinical microbiology. Washington (DC): American Society for Microbiology; 1999;p. 604–613
  5. Campos J, Hernando M, Román F, Pérez-Vázquez M, Aracil B, Oteo J, et al. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 2004;42:524–529
  6. Centers for Disease Control and Prevention (CDC) . Progress towards elimination of Haemophilus influenzae type b invasive disease among infants and children—United States, 1998–2000. MMWR Morb. Mortal. Wkly. Rep. 2002;51:234–237
  7. De Almeida AECC, de Filippis I, Abreu AO, Ferreira DG, Gemal AL, Marzochi KBF. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine. Braz. J. Med. Biol. Res. 2005;38:777–781
  8. De Andrade ALSS, Brandileone MC, DiFabio JL, Oliveira RM, Silva SA, Baiocchi SSA, et al. Haemophilus influenzae resistance in Latin America: systemic review of surveillance data. Microb. Drug Resist. 2001;7:403–413
  9. Doern GV, Jorgensen JH, Thornsberry D, Preston A the Haemophilus influenzae Surveillance group. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: A collaborative study. Diagn. Microbiol. Infect. Dis. 1986;4:95–107
  10. Dominguez SR, Daum RS. Toward global Haemophilus influenzae type b immunization. Clin. Infect. Dis. 2003;37:1600–1602
  11. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101:163–165
  12. FUNASA—http://www.funasa.gov.br - Boletim Eletrônico Epidemiológico-12/06/2003.
  13. Green M, Wald ER. Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting. Ann. Allergy Asthma Immunol. 1996;77:167–173
  14. Hammitt LL, Block S, Hennessy TW, DeByle C, Peters H, Parkinson A, et al. Outbreak of invasive Haemophilus influenzae serotype a disease. Pediatr. Infect. Dis. J. 2005;24:453–456
  15. Heath PT, Booy R, Azzopardi HJ, Slack MPE, Fogarty J, Moloney AC, et al. Non-type b Haemophilus influenzae disease: Clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr. Infect Dis. J. 2001;20:300–305
  16. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance Study. Antimicrob. Agents Chemother. 1999;1901–1908
  17. Jones R. The impact of antimicrobial resistance: Changing epidemiology of community acquired respiratory-tract infections. Am J. Health Syst. Pharm. 1999;56:S4–S11
  18. Jordans JZ, Slack MP. Haemophilus influenzae: then and now. Eur. J. Clin. Microbiol. Infect. Dis. 1995;14:935–948
  19. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin. Infect. Dis. 1992;14:1119–1123
  20. Koeth LM, Felmingham D, Jacobs MR, Rossi F. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. Int. J. Antimicrob. Agents. 2004;23:356–361
  21. LaClaire LL, Tondella MLC, Beall DS, Noble CA, Raghunathan PL, Rosenstein NE, et al. Identification of Haemophilus influenzae by standard slide agglutination serotyping and PCR-based capsulated typing. J. Clin. Microbiol. 2003;41:393–396
  22. Mendes C, Kiffer CRV, Blosser-Middleton RS, Jones ME, Karlowsky JA, Barth A, et al. Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens—a Brazilian perspective from the GLOBAL Surveillance Initiative 2001–2002. Clin. Microbiol. Infect. 2004;10:521–526
  23. Mühlemann K, Balz M, Aebi S, Schopfer K. Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: Analysis of strains isolated between 1986 and 1993. J. Clin. Microbiol. 1996;34:560–563
  24. National Committee for Clinical Laboratory Standards . Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standard M7-A5 5th ed.. Wayne, PA: USA NCCLS; 2000;
  25. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1972;1:283–288
  26. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J. Exp. Med. 1931;53:471–492
  27. Reis JN, Lima JB, Ribeiro GS, Cordeiro SM, Salgado K, Reis MG, et al. Antimicrobial resistance in Haemophilus influenzae isolated during population-based surveillance for meningitis in Salvador, Brazil. Antimicrob. Agents Chemother. 2002;46:3641–3643
  28. Reynolds R, Shachcloth J, Felmingham D, MacGowan A. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: The BSAC respiratory resistance surveillance program. J. Antimicrob. Chemother. 2003;52:925–930
  29. Russel FM, Carapetis JR, Mansoor O, Darcy A, Fakakovi T, Metai A, et al. High incidence of Haemophilus influenzae type b infection in children in pacific island countries. Clin. Infect. Dis. 2003;37:1593–1599
  30. Sader HS, Sampaio J, Zoccoli C, Jones RN. Results of the 1997 SENTRY antimicrobial surveillance program in three Brazilian medical centers. Braz. J. Infect. Dis. 1999;3:63–79
  31. Satola SW, Schirmer PL, Farley MM. Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infect. Immun. 2003;3639–3644
  32. World Health Organization (WHO) . The use of essential drugs. Sixth report of the WHO Expert Committee. Geneva: World Health Organization; 1995;

PII: S0732-8893(05)00188-4

doi: 10.1016/j.diagmicrobio.2005.08.001

Diagnostic Microbiology & Infectious Disease
Volume 54, Issue 1 , Pages 57-62 , January 2006

Article Tools